Laparoscopic urological surgery has become a cornerstone in the management of diverse urological pathologies, offering substantial advantages over traditional open approaches. These benefits include minimized incisions, reduced tissue trauma, decreased intraoperative blood loss, lower postoperative pain, shorter hospital stays, superior cosmesis, and accelerated recovery. Despite these advantages, laparoscopic surgery carries inherent risks, with major vascular injury (MVI) representing one of the most severe and potentially life-threatening complications. This review examines the incidence, etiologies, and management strategies for MVI in laparoscopic urological surgery, emphasizing the critical role of early recognition, standardized protocols, and surgical expertise in optimizing patient outcomes.
BACKGROUND: Bacillus Calmette–Guerin (BCG) is the standard adjuvant treatment for intermediate and high-risk non-muscle invasive bladder cancer (NMIBC) following transurethral resection of the bladder (TURB). However, the optimal dose, strain, and schedule of BCG remain unclear. OBJECTIVE: To evaluate the impact of BCG dose reduction on oncological outcomes and toxicity in patients with non-muscle invasive bladder cancer. METHODS: We performed a systematic review of the literature in PubMed, EMBASE, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov databases. Selected studies were analyzed for Meta Analysis using PRISMA criteria. The study focused on disease recurrence, progression, and toxicity. We also compared the oncological outcomes of the different BCG strains. RESULTS: A total of 2963 patients in 13 randomized controlled trials were included. In recurrence analysis, we found a non-significant difference between the full dose and any dose reduction of BCG (RR = 1.17, [1.06–1.28], I2 = 0%, p = 0.7). In terms of progression, the difference was also non-statistically significant (RR: 1.12 [0.89 - 1.41], I2 = 0%, p = 0.93). In the toxicity analysis, there were more local (RR: 0.81 [0.67–0.99] I2 = 76%; p < 0.01) and systemic (RR: 0.53 [0.34–0.82] I2 = 83%; p < 0.01) side effects in the full dose group than in the dose reduction group. There were no statistically significant differences in oncological outcomes between the analyzed BCG strains. CONCLUSIONS: Dose reduction did not affect the oncological outcomes of patients with NMIBC who received adjuvant therapy with BCG. On the other hand, dose reduction showed a significant trend towards fewer systemic and local side effects. Further studies comparing oncological and toxicity outcomes using different strains are needed.
Objective: Description of the laparoscopic approach for local recurrence of renal cell carcinoma after radical nephrectomy and oncological outcomes. Study design: A retrospective cohort analysis. Materials and methods: A retrospective cohort analysis included patients who underwent laparoscopic resection for RCC recurrence at XXX. The laparoscopic technique utilized either transabdominal or retroperitoneal approaches. The primary outcome measure was disease-free survival. Secondary outcome measures included operative time, estimated blood loss, and complications. Results: Thirteen patients underwent laparoscopic resection, with a mean operative time of 189 minutes and low complication rates. Pathological reports confirmed clear-cell RCC in the majority of cases. The median time to recurrence post-nephrectomy was 67 months, with a 3-year disease-free survival rate of 85%. All patients had negative margins, and at the last follow-up all patients were alive. Limitations: The limitations of this study include its small sample size and retrospective design. Value: The full laparoscopic approach for patients with local recurrence of renal cell carcinoma. Conclusion: Laparoscopic resection of locally recurrent RCC post-radical nephrectomy appears to be safe and effective, demonstrating promising oncological outcomes. Larger prospective studies are warranted to validate these findings and establish standardized guidelines for widespread implementation.
Laparoscopic urological surgery has become a cornerstone in the treatment of various urological conditions, offering significant advantages over traditional open surgical approaches. These include smaller incisions, less tissue trauma, reduced intraoperative bleeding, less postoperative pain, shorter hospital stays, better cosmetic outcomes, and faster recovery times. Despite these benefits, laparoscopic surgery is not without risks, and major vascular injury (MVI) is one of the most severe and potentially life-threatening complications. This review explores the incidence, causes, and management strategies for MVI in laparoscopic urological surgery, highlighting the importance of early recognition, standardized protocols, and surgical expertise to optimize patient outcomes.
Introduction: nephron-sparing surgery (NSS) has emerged as the preferred treatment for renal tumors, aiming to balance oncological outcomes and renal function preservation. Partial nephrectomy (PN) has shown comparable cancer-specific survival rates to radical nephrectomy (RN). Notably, postoperative renal damage is associated with both ischemia time and parenchymal loss, emphasizing the importance of preserving renal function during tumor resection. The R.E.N.A.L. Nephrometry Score (RNS), has enhanced the quantification of renal tumor characteristics and improved standardization, guiding surgical decisions. This study aims to describe different hilum approaches based on RNS during laparoscopic PN and analyze their impact on surgical time, intraoperative bleeding, and functional outcomes. Methods: a retrospective analysis of 90 laparoscopic partial nephrectomy cases was conducted. Surgical time, estimated blood loss (EBL), renal hilum approach (including hilum dissection with renal artery clamping [HD&RAC], hilum dissection without renal artery clamping [HD&noRAC], and no hilum dissection with no renal artery clamping [noHD&noRAC), complication rates and RNS-guided complexity (low: RNS < 7, intermediate: RNS 7-9, high: RNS > 9) were assessed. The choice of hilum approach and abdominal access was determined by the physician based on tumor complexity assessed using RNS. Results: surgical time varied significantly between hilum approaches, with HD&RAC being the longest (196min), followed by HD&noRAC (147min) and noHD&noRAC (130min). The mean surgical time was statistically significantly different between HD&RAC and HD&noRAC (p-value = 0.0005) and between HD&RAC and noHD&noRAC (p-value = 0.0001). Intraoperative bleeding was higher in the HD&RAC approach than the noHD&noRAC approach (p-value = 0.039). Pre- and post-surgery glomerular filtration rates did not significantly differ by hilum approach (p= 0.7255) or complexity of the renal mass (p= 0.5633). No intraoperative complications were reported. However, three patients with high RNS experienced postoperative urinary fistulas. Conclusion: the choice of renal hilum approach significantly impacts surgical time and intraoperative bleeding during laparoscopic partial nephrectomy. Using RNS to guide the approach selection allows for optimal surgical outcomes without compromising glomerular filtration rate (GFR). Further research is needed to validate these findings in larger, multicenter studies and assess long-term outcomes associated with different hilum approaches in laparoscopic PN.